ASCO GU 2018 Prostate Cancer
Viewing 81-88 of 88 articles
ASCO GU 2018: Randomised Phase III Trial of Enzalutamide in Androgen Deprivation Therapy with Radiation Therapy for High Risk, Clinically Localized Prostate Cancer: ENZARAD (ANZUP 1303)
ASCO GU 2018: The Association Between Physician Trust and Prostate Specific Antigen Screening: Implications for Shared Decision Making.
ASCO GU 2018: The Perineural Invasion Paradox: Is Perineural Invasion an Independent Prognostic Indicator of Biochemical Recurrence Risk in Patients with pT2N0 Prostate Cancer?
ASCO GU 2018: Case-Based Debate: Magnetic Resonance and Magnetic Resonance-Directed Biopsy: Where is the Field Moving?